CADASIL is one of the most common genetic causes of stroke and dementia. Currently there is no treatment for CADASIL. In this study, human stem cells will be generated from a piece of skin donated by patients with CADASIL. From these stem cells, smooth muscle cells (SMCs) will be generated in a tissue culture dish in the lab.
Announced today, AMRC Open Research is a new online platform for publishing medical research findings and is co-funded by the Stroke Association.
Our new report, ‘Current, future and avoidable costs of stroke in the UK’, suggests that investing in stroke research today could lead to a significant reduction in the burden of stroke in the future.
We need your support to continue to invest in research that will help to save lives and enable stroke survivors to make the best possible recovery.
The aim of this research programme is to develop a human brain bank to support biomedical research into the pathophysiology of human SVD that may be used nationally and internationally.
People with stroke due to brain haemorrhage have swelling around the haemorrhage on their brain scan. More swelling worsens recovery. No treatment improves outcome after this swelling.
The programme will use biological information about cells and molecules, and information from patients, to design a study of treatment for swelling after brain haemorrhage.
The Stroke Association's Keynote Lecture is a prestigious event which showcases the latest advancements being made in stroke research.
Find out more about our Keynote Lecture 2015
The Stroke Priority Setting Partnership is being guided by a Steering Group. Members include people affected by stroke, health and social care professionals, and those in supporting roles. Where two people are named for one organisation, they are sharing one place.